Tuesday, May 2, 2023

Researchers have found in a new study that the investigational drug LX9211 is a novel, non-opioid treatment option for post-herpetic neuralgia.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)